Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 1/20 | 0.63 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.58 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.58 |
| ▸ | S1PR2 | O95136 | 5/20 | 0.58 |
| ▸ | S1PR1 | P21453 | 5/20 | 0.58 |
| ▸ | S1PR3 | Q99500 | 5/20 | 0.58 |
| ▸ | S1PR4 | O95977 | 4/20 | 0.58 |
| ▸ | SPHK1 | Q9NYA1 | 2/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | TP53 | P04637 | 2/20 | 0.48 |
| ▸ | LAP3 | P28838 | 2/20 | 0.48 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.46 |
| ▸ | GMNN | O75496 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | THPO | P40225 | 1/20 | 0.46 |
| ▸ | MTOR | P42345 | 1/20 | 0.46 |
| ▸ | BLM | P54132 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4952280 | 0.97 | PLA2G1B (0.62) | OPRM1PLA2G1BPLA2G2AS1PR2S1PR1 | |
| SCHEMBL5873613 | 0.97 | PLA2G1B (0.62) | OPRM1PLA2G1BPLA2G2AS1PR2S1PR1 | |
| SCHEMBL20746426 | 0.97 | PLA2G1B (0.62) | OPRM1PLA2G1BPLA2G2AS1PR2S1PR1 | |
| SCHEMBL11289661 | 0.97 | PLA2G1B (0.62) | OPRM1PLA2G1BPLA2G2AS1PR2S1PR1 | |
| SCHEMBL1507463 | 0.97 | PLA2G1B (0.62) | OPRM1PLA2G1BPLA2G2AS1PR2S1PR1 | |
| SCHEMBL23141152 | 0.97 | PLA2G1B (0.62) | OPRM1PLA2G1BPLA2G2AS1PR2S1PR1 | |
| SCHEMBL20746346 | 0.97 | PLA2G1B (0.62) | OPRM1PLA2G1BPLA2G2AS1PR2S1PR1 | |
| SCHEMBL20746505 | 0.97 | PLA2G1B (0.62) | OPRM1PLA2G1BPLA2G2AS1PR2S1PR1 | |
| SCHEMBL20746344 | 0.97 | PLA2G1B (0.62) | OPRM1PLA2G1BPLA2G2AS1PR2S1PR1 | |
| SCHEMBL447127 | 0.97 | PLA2G1B (0.62) | OPRM1PLA2G1BPLA2G2AS1PR2S1PR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 326 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250114479-A1 | TISSUE-SELECTIVE SINGLE-COMPONENT MRNA DELIVERY CARRIER AND DELIVERY SYSTEM | INSTITUTE OF PROCESS ENGINEERING , CHINESE ACADEMY OF SCIENCES (CN) | 2025-04-10 | — | — | US | claimed |
| CN-118834075-A | Ceramic powder and preparation method and application thereof | 南充三环电子有限公司 | 2024-10-25 | — | — | CN | claimed |
| WO-2024183010-A1 | TISSUE-SELECTIVE SINGLE-COMPONENT MRNA DELIVERY CARRIER AND DELIVERY SYSTEM | 中国科学院过程工程研究所 | 2024-09-12 | — | — | WO | claimed |
| CN-116178219-B | Chiral diarylmethylamine compound and preparation method thereof | 上海工程技术大学 | 2024-06-28 | — | — | CN | claimed |
| CN-115991633-B | Method for preparing methanol and ethylene glycol and co-producing formic acid by photocatalysis of polyalcohol | 中国科学院大连化学物理研究所 | 2024-06-25 | — | — | CN | claimed |
| CN-117479964-A | Tissue-selective single-component mRNA delivery vector and delivery system | 中国科学院过程工程研究所 | 2024-01-30 | — | — | CN | claimed |
| CN-116554119-A | Enantioselective reduction (hetero) arylation method of cobalt-catalyzed cyclic N-sulfonyl imine and application | 上海毕得医药科技股份有限公司 | 2023-08-08 | — | — | CN | claimed |
| CN-116178219-A | Chiral diarylmethylamine compound and preparation method thereof | 上海工程技术大学 | 2023-05-30 | — | — | CN | claimed |
| CN-115991633-A | Method for preparing methanol and ethylene glycol and co-producing formic acid by photocatalysis of polyalcohol | 中国科学院大连化学物理研究所 | 2023-04-21 | — | — | CN | claimed |
| CN-114702457-A | Green synthesis method of diarylmethylamine compound | 青岛科技大学 | 2022-07-05 | — | — | CN | claimed |
| WO-2020019911-A1 | BORON NITROGEN LIGAND BASED ON CHIRAL 1,2-ETHYLENEDIAMINE BACKBONE AND PREPARATION METHOD AND USE THEREOF | 中国科学院兰州化学物理研究所苏州研究院 | 2020-01-30 | — | — | WO | claimed |
| EP-2552347-B1 | METHOD FOR STIMULATING THE REPRODUCTIVE CAPACITY IN A BULL, AND COMPOSITION FOR STIMULATING THE REPRODUCTIVE CAPACITY IN A BULL | AGRONOMIQUE INST NAT RECH (FR) | 2015-08-12 | — | — | EP | claimed |
| US-20130203844-A1 | Method for Stimulating the Reproductive Capacity in a Bull, and Composition for Stimulating the Reproductive Capacity in a Bull | INSTITUT NATIONAL DE LA RECHERCHE AGRONOMIQUE (FR) | 2013-08-08 | — | — | US | claimed |
| EP-2552347-A1 | METHOD FOR STIMULATING THE REPRODUCTIVE CAPACITY IN A BULL, AND COMPOSITION FOR STIMULATING THE REPRODUCTIVE CAPACITY IN A BULL | Institut National de la Recherche Agronomique (FR) | 2013-02-06 | — | — | EP | claimed |
| WO-2011120930-A1 | METHOD FOR STIMULATING THE REPRODUCTIVE CAPACITY IN A BULL, AND COMPOSITION FOR STIMULATING THE REPRODUCTIVE CAPACITY IN A BULL | INSTITUT NATIONAL DE LA RECHERCHE AGRONOMIQUE (FR) | 2011-10-06 | — | — | WO | claimed |
| US-20110015198-A1 | DIARYLMETHYLAMIDE DERIVATIVE HAVING MELANIN-CONCENTRATING HORMONE RECEPTOR ANTAGONISM | BANYU PHARMACEUTICAL CO., INC. | 2011-01-20 | — | — | US | claimed |
| EP-2272841-A1 | DIARYLMETHYLAMIDE DERIVATIVE HAVING ANTAGONISTIC ACTIVITY ON MELANIN-CONCENTRATING HORMONE RECEPTOR | Banyu Pharmaceutical Co., Ltd. (JP) | 2011-01-12 | — | — | EP | claimed |
| WO-2001092420-A2 | PERYLENE DYES WITH PERSISTENT FLUORESCENCE CAUSED BY STERIC INHIBITION OF AGGREGATION | RADIANT COLOR N.V. (BE) | 2001-12-06 | — | — | WO | claimed |
| US-6080857-A | CONTACTING AN AMINE NUCLEOPHILE WITH AN A,B-UNSATURATED AMIDE DERIVATIVE SUCH AS ACYL UREA, OR CARBOXYLIC IMIDE IN THE PRESENCE OF A CHIRAL LEWIS ACID COMPLEX OF A CHIRAL BISOXAZOLINYLMETHANE WITH AN AZOPHILIC METACATION SALT | NORTH DAKOTA STATE UNIVERSITY (US) | 2000-06-27 | — | — | US | claimed |
| EP-0235942-B1 | Alkylenediamine derivatives | NIPPON CHEMIPHAR CO (JP) | 1994-03-23 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250114479-A1 | TISSUE-SELECTIVE SINGLE-COMPONENT MRNA DELIVERY CARRIER AND DELIVERY SYSTEM | SLC43A1, LNPEP, TLR3 | OPRM1 390/4885PLA2G1B 2943/4885PLA2G2A 2086/4885 |
| US-20110015198-A1 | DIARYLMETHYLAMIDE DERIVATIVE HAVING MELANIN-CONCENTRATING HORMONE RECEPTOR ANTAGONISM | MC1R, MCHR2, MCHR1 | OPRM1 155/4885PLA2G1B 2347/4885PLA2G2A 1387/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.